Will This Obamacare Rule Hurt Baby Formula Sales? (ABT, MJN)

Will This Obamacare Rule Hurt Baby Formula Sales?

At more than 900 pages in length, the Affordable Care Act is a massive piece of legislation. While a few provisions of the law get the lion's share of attention, laws don't get that long without at least a few obscure provisions finding their way into the final version.

In the following video, Brenton Flynn highlights an Obamacare rule that's meant to promote the adoption of breastfeeding with new mothers. With employers now required to accommodate new mothers with dedicated rooms, and insurers mandated to cover specialized consulting services and equipment rental, it's a provision that just might put a dent in the sales of companies selling infant formula like Abbott Labs (NYSE: ABT ) and Mead Johnson Nutrition (NYSE: MJN ) .

While infant nutrition is an important part of its business, Abbott Labs is more than just a baby formula maker. To help investors better understand the company, The Motley Fool has created a brand new premium report on Abbott Labs. Inside we outline all of the must-know opportunities and risks facing the company -- and also provide a full year of updates -- so make sure to claim this report by clicking here now.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.